Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy

被引：0
|
作者：
Ying-Jui Chao
Edgar D Sy
Hui-Ping Hsu
Yan-Shen Shan
机构：
[1] Department of Surgery,Division of General Surgery
[2] National Cheng Kung University Hospital,Institute of Clinical Medicine
[3] College of Medicine,undefined
[4] National Cheng Kung University,undefined
来源：
BMC Surgery | / 14卷
关键词：
Locally advanced pancreatic cancer (LAPC); Neoadjuvant therapy; Concurrent chemoradiation therapy (CCRT);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
    Chao, Ying-Jui
    Sy, Edgar D.
    Hsu, Hui-Ping
    Shan, Yan-Shen
    [J]. BMC SURGERY, 2014, 14
  • [2] Resectability After Concurrent Gemcitabine-Based Chemoradiation Therapy for Patients With Locally-Advanced Pancreatic Cancer
    Skamene, S.
    Niazi, T.
    Kopek, N.
    Vanounou, T.
    Vuong, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S315 - S316
  • [3] Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
    Sahora, K.
    Schindl, M.
    Kuehrer, I.
    Werba, G.
    Fitzal, F.
    Goetzinger, P.
    Gnant, M.
    [J]. EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2013, 45 (03): : 169 - 178
  • [4] Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
    K. Sahora
    M. Schindl
    I. Kuehrer
    G. Werba
    F. Fitzal
    P. Goetzinger
    M. Gnant
    [J]. European Surgery, 2013, 45 : 169 - 178
  • [5] Restaging and assessment of resectability of locally advanced pancreatic cancer by EUS after neoadjuvant therapy
    Walker, Jon
    Chaudhary, Uzair
    Nestor, Esnaola E.
    Romagnuolo, Joseph
    Hawes, Robert H.
    Hoffman, Brenda
    [J]. GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB212 - AB213
  • [6] Restaging and assessment of resectability of locally advanced pancreatic cancer by EUS after neoadjuvant therapy
    Walker, Jon
    Chaudhary, Uzair
    Esnaola, Nestor
    Romagnuolo, Joseph
    Hawes, Robert
    Hoffman, Brenda
    [J]. GASTROINTESTINAL ENDOSCOPY, 2009, 69 (02) : S266 - S266
  • [7] Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
    Michelakos, Theodoros
    Pergolini, Ilaria
    Fernandez-del Castillo, Carlos
    Honselmann, Kim C.
    Cai, Lei
    Deshpande, Vikram
    Wo, Jennifer Y.
    Ryan, David P.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Murphy, Janet E.
    Nipp, Ryan D.
    Parikh, Aparna
    Qadan, Motaz
    Warshaw, Andrew L.
    Hong, Theodore S.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    [J]. ANNALS OF SURGERY, 2019, 269 (04) : 733 - 740
  • [8] Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX
    Hu, Hai-Jie
    Li, Fu-Yu
    [J]. ANNALS OF SURGERY, 2018, 268 (06) : E95 - E96
  • [9] Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
    Gemenetzis, Georgios
    Groot, Vincent P.
    Blair, Alex B.
    Laheru, Daniel A.
    Zheng, Lei
    Narang, Amol K.
    Fishman, Elliot K.
    Hruban, Ralph H.
    Yu, Jun
    Burkhart, Richard A.
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    [J]. ANNALS OF SURGERY, 2019, 270 (02) : 340 - 347
  • [10] Helical tomotherapy and concurrent gemcitabine-based chemotherapy for locally advanced pancreatic cancer
    Seong, Jinsil
    Chang, Jisuk
    Song, Siyoung
    Keum, Woong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345